Schizophrenia Research
Volume 86, Issue 1 , Pages 36-44 , September 2006

A lifestyle intervention for older schizophrenia patients with diabetes mellitus: A randomized controlled trial

  • Christine L. McKibbin

      Affiliations

    • University of California, San Diego, United States
    • Department of Veterans' Affairs, San Diego Health Care System, United States
    • Corresponding Author InformationCorresponding author. VA San Diego Healthcare System, Department of Psychiatry, Bldg. 13, 2nd Floor, 3350 La Jolla Village Drive, San Diego, CA 92161, United States. Tel.: +1 858 552 8585x2746; fax: +1 858 552 7404.
    • ,
  • Thomas L. Patterson

      Affiliations

    • University of California, San Diego, United States
    • Department of Veterans' Affairs, San Diego Health Care System, United States
    • ,
  • Gregory Norman

      Affiliations

    • University of California, San Diego, United States
    • ,
  • Kevin Patrick

      Affiliations

    • University of California, San Diego, United States
    • ,
  • Hua Jin

      Affiliations

    • University of California, San Diego, United States
    • Department of Veterans' Affairs, San Diego Health Care System, United States
    • ,
  • Scott Roesch

      Affiliations

    • San Diego State University, United States
    • ,
  • Sunder Mudaliar

      Affiliations

    • University of California, San Diego, United States
    • Department of Veterans' Affairs, San Diego Health Care System, United States
    • ,
  • Concepcion Barrio

      Affiliations

    • San Diego State University, United States
    • ,
  • Kathleen O'Hanlon

      Affiliations

    • Department of Veterans' Affairs, San Diego Health Care System, United States
    • ,
  • Kay Griver

      Affiliations

    • Department of Veterans' Affairs, San Diego Health Care System, United States
    • ,
  • A'verria Sirkin

      Affiliations

    • University of California, San Diego, United States
    • Department of Veterans' Affairs, San Diego Health Care System, United States
    • ,
  • Dilip V. Jeste

      Affiliations

    • University of California, San Diego, United States
    • Department of Veterans' Affairs, San Diego Health Care System, United States

Received 23 February 2006 ,Revised 5 May 2006 ,Accepted 11 May 2006.

References 

  1. American Diabetes Association , American Psychiatric Association , American Association of Clinical Endocrinologists , North American Association for the Study of Obesity . Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004;27:596–601
  2. Anderson RM, Funnell MM, Fitgerald JT, Marrero DG. The diabetes empowerment scale: a measure of psychosocial self-efficacy. Diabetes Care. 2000;23:739–743
  3. Archie S, Wilson JH, Osbourne S, Hobbs H, McNiven J. Pilot study: Access to fitness facility and exercise levels in olanzapine-treated patients. Can. J. Psychiatry. 2003;48:628–632
  4. Beebe LH, Tian L, Morris N, Goodwin A, Allen SS, Kuldau J. Effects of exercise on mental and physical health parameters of persons with schizophrenia. Issues Ment. Health Nurs. 2005;26:661–676
  5. Brar JS, Ganguli R, Pandina G, Turkoz I, Berry S, Mahmoud R. Effects of behavior therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J. Clin. Psychiatry. 2005;66:205–212
  6. Brown JB, Pedula KL, Bakst AW. The progressive cost of complications in type 2 diabetes mellitus. Arch. Intern. Med. 1999;159:1873–1880
  7. Citrome L. Focus on the clinical ramifications of antipsychotic choice for the risk for developing type 2 diabetes mellitus. Int. J. Neuropsychopharmacol. 2004;8:147–151
  8. DiPietro L, Caspersen CJ, Ostfeld AM, Nadel ER. A survey for assessing physical activity among older adults. Med. Sci. Sports Exerc. 1993;25:628–642
  9. Evans S, Newton R, Higgins S. Nutritional intervention to prevent weight gain in patients commenced on olanzapine: a randomized controlled trial. Aust. N. Z. J. Psychiatry. 2005;39:479–486
  10. Fitzgerald JT, Anderson RM, Funnell MM, Hiss RG, Hess GE, Davis WK, et al. The reliability and validity of a brief diabetes knowledge test. Diabetes Care. 1998;21:706–710
  11. Goldstein DJ. Beneficial health effects of modest weight loss. Int. J. Obes. Relat. Metab. Disord. 1992;16:397–415
  12. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967;6:278–296
  13. Harmatz MG, Lapuc P. Behavior modification of overeating in a psychiatric population. J. Consult. Clin. Psychol. 1968;32:583–587
  14. Henderson DC. Schizophrenia and comorbid medical disorders. J. Clin. Psychiatry. 2005;66:11–20
  15. Jin H, Meyer JM, Jeste DV. Atypical antipsychotics and glucose dysregulation: A systematic review. Schizophr. Res. 2004;71:195–212
  16. Kay SR, Opler LA, Fiszbein A. Positive and Negative Syndrome Scale (PANSS) Rating Manual. San Rafael, CA: Social and Behavioral Sciences Documents; 1987;
  17. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker Ea, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002;346:393–403
  18. Lamberti JS, Crilly JF, Maharaj K, Olson D, Wiener K, Dvorin S, et al. Prevalence of diabetes mellitus among outpatients with severe mental disorders receiving atypical antipsychotic drugs. J. Clin. Psychiatry. 2004;65:702–706
  19. Littrell KH, Hilligoss NM, Kirshner CD, Petty RG, Johnson CG. The effects of an educational intervention on antipsychotic-induced weight gain. J. Nurs. Scholarsh. 2003;35:237–241
  20. Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, et al. Physical health monitoring of patients with schizophrenia. Am. J. Psychiatry. 2004;161:1334–1349
  21. Mattis S. Dementia Rating Scale. Odessa, FL: Psychological Assessment Resources, Inc.; 1973;
  22. McCreadie RG, Kelly C, Connolly M, Williams S, Baxter G, Lean M, et al. Dietary improvement in people with schizophrenia: randomised controlled trial. Br. J. Psychiatry. 2005;187:346–351
  23. Mensing C, Boucher J, Cypress M, Weinger K, Mulcahy K, Barta P, et al. National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs. Diabetes Care. 2000;23:682–689
  24. Menza M, Vreeland B, Minsky S, Gara M, Radler DR, Sakowitz M. Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. J. Clin. Psychiatry. 2004;65:471–477
  25. Miller CK, Edwards L, Kissling G, Sanville L. Evaluation of a theory-based nutrition intervention for older adults with diabetes mellitus. J. Am. Diet. Assoc. 2002;102:1069–1081
  26. Olefsky J, Reaven GM, Farquhar JW. Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects. J. Clin. Invest. 1974;53:64–76
  27. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537–544
  28. Patterson TL, McKibbin CL, Taylor MJ, Goldman S, Davila-Fraga W, Bucardo J, et al. Functional Adaptation Skills Training (FAST): a pilot psychosocial intervention study in middle-aged and older patients with chronic psychotic disorders. Am. J. Geriatr. Psychiatry. 2003;11:17–23
  29. Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S, et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care. 2005;28:2130–2135
  30. Rotatori AF, Fox R, Wicks A. Weight loss with psychiatric residents in a behavioral self control program. Psychol. Rep. 1980;46:483–486
  31. Toolbert DJ, Strycker LA, Glasgow RE, Barrera M, Bagdade JD. Enhancing support for health behavior change among women at risk for heart disease: the Mediterranean Lifestyle Trial. Health Educ. Res. 2002;17:574–585
  32. Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004;27:155–161
  33. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 2001;344:1343–1350
  34. UKPDS Group . UK Prospective Diabetes Study 7: response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients. Metabolism. 1990;39:905–912
  35. Wang J, Thornton JC, Bari S, Williamson B, Gallagher D, Heymsfield SB, et al. Comparison of waist circumferences measured at 4 sites. Am. J. Clin. Nutr. 2003;77:379–384
  36. Wannamethee SG, Shaper AG, Walker M. Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes. J. Epidemiol. Community Health. 2005;59:134–139
  37. Williams KV, Kelley DE. Metabolic consequences of weight loss on glucose metabolism and insulin action in type 2 diabetes. Diabetes Obes. Metab. 2000;2:121–129
  38. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch. Intern. Med. 2002;162:1867–1872
  39. World Health Organization . WHO Psychiatric Disability Assessment Schedule (WHO/DAS: With a Guide to Its Use). Geneva: WHO; 1988;

☆ This work was supported, in part, by the National Institute of Mental Health grants MH063139, MH66248, MH063139, MH62554, RR00827 and by the Department of Veterans Affairs.

PII: S0920-9964(06)00237-4

doi: 10.1016/j.schres.2006.05.010

Schizophrenia Research
Volume 86, Issue 1 , Pages 36-44 , September 2006

Article Tools